Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 7, Issue 6, 2004, Pages 488-492

  Yi, Jun ^a   Pan, Tiecheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Immunohistochemical method; NCSLC; Prognosis; VEGF C; VEGF R3

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 11244336521     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kajita T, Ohta Y, Kimura K, et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer, 2001, 85(2): 255-260.
2. Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer, 1996, 78(10): 2111-2118.
3. Arinaga M, Noguchi T, Takeno S, et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with non-small cell lung carcinoma. Cancer, 2003, 97(2): 457-464.
4. Che XM, Xu YF, Wang K, et al. Expression of VEGF and its relationship with lymph node metastasis in early gastric cancer. Chin J Gastronintest Surg, 2002, 12(5): 285-287.
5. Niki T, Iba S, Yamada T, et al. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol, 2001, 193(4): 450-457.
6. Niki T, Iba S, Tokunou M, et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res, 2000, 6(6): 2431-2439.
7. Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2000, 119(4 Pt 1): 804-813.
8. Li QL. Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor. Chin J Cancer, 2002, 21(6): 696-700.
9. Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer, 2001, 37(7): 918-923.
10. O-Charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer, 2001, 92(3): 556-568.
11. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 1997, 276(5317): 1423-1425.
12. Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg, 2002, 74(1): 278-284.